Key Insights
Every investor in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion’s share in the company with 49% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
Meanwhile, private companies make up 36% of the company’s shareholders.
In the chart below, we zoom in on the different ownership groups of Shanghai Fosun Pharmaceutical (Group).
Check out our latest analysis for Shanghai Fosun Pharmaceutical (Group)
What Does The Institutional Ownership Tell Us About Shanghai Fosun Pharmaceutical (Group)?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant…
